The Niche
The Niche (ipscell.com) is a specialized science and policy news outlet focused on stem cell research and adjacent areas of biomedicine.
- Indexed articles, last 90 days
- 9
- Latest publication
- Aug 2, 2026
- Audience
- Top 10M sites
- Earliest in this view
- Jul 5, 2026
Latest articles
Weekly reads: FDA warning, Capricor pub vs. AdCom, stem cells can count, hydra regeneration (opens the original)
Read excerpt
How well do FDA warning and untitled letters address what the agency sees as noncompliant activities by unproven stem cell clinics and supplier firms? One might think these letters work well given the implicit threat that not complying with them could lead to more severe action. For instance, the FDA can seek injunctions. Yet, that […] The post Weekly reads: FDA warning, Capricor pub vs. AdCom, stem cells can count, hydra regeneration appeared first on <a hr
A Look Back on ISSCR 2026: the most exciting research (opens the original)
Read excerpt
They say you never forget your first international conference. They’re right. Last week, I attended ISSCR 2026 as an undergraduate student. I was admittedly nervous at the start, but by the time the end of the second day rolled around, and with it the all-attendee reception, all the ice had melted and the excitement was […] The post A Look Back on ISSCR 2026: the most exciting research appeared first on The Niche.</p
More farce or tragedy? What’s ahead after RFK Jr.’s PCAC kangaroo meeting green lit risky peptides (opens the original)
Read excerpt
As I was watching the PCAC meetings late last week on popular so-called wellness or pop peptides, a neologism jumped to mind: kangaroo meeting. I almost felt like this PCAC meeting was a theatrical play. I can’t decide if it was more tragedy or farce. We watched as some conflicted panel members participated and voted […] The post More farce or tragedy? What’s ahead after RFK Jr.’s PCAC kangaroo meeting green lit risky peptides appe
Weekly reads: MYC phosphorylation, reverse protein aging, mitochondria don’t like space, that peptide committee (opens the original)
Read excerpt
Why am I interested in MYC phosphorylation? What is MYC? Long-time readers of The Niche probably remember that the MYC family is one of my primary interests. These proteins are essential for normal development (and stem cell function) as well as contributing to the formation of many tumors when overexpressed or mutated. MYC was also […] The post Weekly reads: MYC phosphorylation, reverse protein aging, mitochondria don’t like space, th
Potentially highly-conflicted PCAC meets this week on pop peptides, but no waivers (opens the original)
Read excerpt
So-called wellness peptides are even more in the spotlight this week as the pharmacy compounding advisory committee or PCAC launches a series of meetings to evaluate restoration of compounding of these unproven peptide drugs. This committee is supposed to take FDA staff guidance into consideration as it decides what to recommend to the agency. Typically […] The post Potentially highly-conflicted PCAC meets this week on pop peptides, but no waivers appeared first
Publishing over time
Last 90 days. Choose a month to open its work.
Recurring subjects
Named in the text we hold. One piece can cover several.
Audience
Top 10M sites
Measured Aug 1, 2026
Website popularity band, not a count of readers or article views.
About this data
Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.
Identity or attribution wrong? Suggest a correction.